DANIEL LYNCH Insider Trading $SURF Surface Oncology, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DANIEL LYNCH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DANIEL LYNCH. DANIEL LYNCH is Acting Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and in bluebird bio, Inc. ($BLUE) and Director in bluebird bio, Inc. ($BLUE) and Director in BIND Therapeutics, Inc ($BIND) and Director in Eleven Biotherapeutics, Inc. ($EBIO) and Director in Blueprint Medicines Corp ($BPMC) and Director in Translate Bio, Inc. ($TBIO) and Director in Surface Oncology, Inc. ($SURF) and Director in SpringWorks Therapeutics, Inc. ($SWTX).

DANIEL LYNCH in Surface Oncology, Inc.

Trading Symbol: SURF
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Latest Transaction: Jun 12 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DANIEL LYNCH in Surface Oncology, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BLUE, BPMC, BIND, IMCLE, SESN, SWTX, SURF, TBIO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 12 2020SURFSurface Oncology, ...LYNCH DANIELDirectorOption ExerciseA4.3512,00052,20012,000
Jun 06 2019SURFSurface Oncology, ...LYNCH DANIELDirectorOption ExerciseA3.6912,10044,64912,100
Jun 06 2019SURFSurface Oncology, ...LYNCH DANIELDirectorOption ExerciseA3.6912,10044,64912,100

Page:   1